Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Albany Molecular Research Inc. (AMRI) has signed a deal to provide sterile fill-and-finish services for AstraZeneca’s COVID-19 vaccine candidate, AZD1222. AMRI will do the work at its facility in Albuquerque, New Mexico. Meanwhile, Inovio has picked Thermo Fisher Scientific to manufacture its DNA COVID-19 vaccine candidate, INO-4800. Thermo Fisher will make the active ingredient and provide fill-and-finish services at plants in the US. Both AstraZeneca and Inovio have several other production partners.
Support nonprofit science journalism
C&EN has made this story and all of its coverage of the coronavirus epidemic freely available during the outbreak to keep the public informed. To support us:
Donate Join Subscribe
This article has been sent to the following recipient: